Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Urinary Tract Infection IV: Nursing Management

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beta Blockers to Improve Post-MI Outcomes in Patients Without HF.

American family physician·2026

Same author

Hyperthyroidism: Diagnosis and Treatment.

American family physician·2025

Same author

Mind over Matter: Tracking Medical Students' Self-perceptions of Wellness at the USMLE Step 1 Juncture.

Medical science educator·2025

Same author

High-Flow Nasal Cannula Therapy for Infants With Bronchiolitis.

American family physician·2025

Same author

A Strategic Approach to Succeed on Clinical Case-Based Multiple-Choice Exams.

MedEdPublish (2016)·2025

Same author

Bempedoic Acid for the Prevention of Cardiovascular Disease.

American family physician·2024

Search research articles

Related Experiment Video

Updated: Dec 29, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Clostridioides difficile Infection: Update on Management.

Anne Mounsey¹, Kelly Lacy Smith¹, Vinay C Reddy¹

¹University of North Carolina School of Medicine, Chapel Hill, NC, USA.

American Family Physician

|February 1, 2020

Summary

This summary is machine-generated.

Updated guidelines for Clostridioides difficile infection (CDI) emphasize prompt diagnosis and tailored treatment. Key recommendations include specific diagnostic tests, preferred initial therapies like oral vancomycin or fidaxomicin, and the role of fecal microbiota transplantation for recurrent cases.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Related Experiment Videos

Last Updated: Dec 29, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Area of Science:

Infectious Diseases
Gastroenterology
Microbiology

Background:

Clostridioides difficile infection (CDI) is a significant healthcare-associated infection.
Risk factors include antibiotic use and healthcare exposure.
Symptoms range from mild diarrhea to life-threatening conditions.

Purpose of the Study:

To summarize recent updates in the diagnosis and treatment guidelines for Clostridioides difficile infection.
To provide evidence-based recommendations for clinical practice.

Main Methods:

Review of updated clinical guidelines.
Analysis of diagnostic strategies including enzyme immunoassays and nucleic acid amplification testing.
Evaluation of treatment options based on infection severity and recurrence.

Main Results:

Updated guidelines recommend specific diagnostic approaches for suspected CDI.
Oral vancomycin or fidaxomicin are preferred for initial non-severe CDI.
Metronidazole is not recommended as first-line therapy for adults; fecal microbiota transplantation is an option for recurrent cases.

Conclusions:

Adherence to updated CDI guidelines is crucial for effective patient management.
Antibiotic stewardship and proper hygiene are key preventive strategies.
Probiotics are not recommended for CDI prevention.